JK Agri Genetics Ltd

JK Agri Genetics reported a challenging financial year ending March 2025, with a net profit of -2.51 crore and an operating profit margin of -6.26%. The company faced significant losses, reflected in a total operating income of 161.79 crore against expenditures of 171.92 crore.

On 21-Nov, JK Agri Genetics Ltd witnessed a significant decline in its share price, falling by 6.27% to close at ₹407.55. This downturn reflects a broader pattern of underperformance relative to market benchmarks and waning investor participation.

JK Agri Genetics reported a challenging financial performance for the year ending March 2025, with an operating loss of -5.02 crore, a profit after tax of -2.51 crore, and significant current liabilities of 188.42 crore, indicating operational difficulties and negative profit margins.

JK Agri Genetics reported a total operating income of 161.79 crore and a loss of 5.02 crore for the year ending March 2025, with a profit after tax of -2.51 crore and an EPS of -5.41. The company had total assets and liabilities of 268.56 crore, significant current liabilities of 188.42 crore, and a closing cash balance of 5.00 crore.

As of 11-Nov, JK Agri Genetics Ltd is experiencing a significant price increase to 450.00, up 10.17%, after a trend reversal following eight days of decline. Despite today's gains, the stock has decreased 4.56% over the past month and 18.76% over five years, with declining investor participation indicating potential volatility.

As of 10-Nov, JK Agri Genetics Ltd's stock price is Rs 414.90, down 1.46% and has declined 10.1% over the last eight days. Despite a stable broader market, the stock has underperformed significantly, with a year-to-date return down by 4.25% compared to the Sensex's gain of 6.91%.

JK Agri Genetics reported a consolidated net profit of -2.51 crore for the year ending March 2025, with total operating income of 161.79 crore and total expenditures of 171.92 crore, resulting in an operating loss of -5.02 crore and significant debt. The company's financial metrics indicate ongoing operational challenges.

As of 03-Nov, JK Agri Genetics Ltd's stock price is Rs 442.25, down 1.83% after four consecutive days of decline totaling 4.17%. The stock has underperformed the Sensex over the past week and month, with significant decreases in trading volume and investor interest.

As of October 30, 2025, JK Agri Genetics is overvalued with a PE ratio of 1044.94 and a negative EV to EBIT of -556.50, making it an expensive investment compared to peers like Elitecon International and PTC India, despite a 12.82% return that underperforms the Sensex's 5.58% return.

JK Agri Genetics' latest Q2 FY26 results are concerning, with a significant revenue drop to ₹19.07 crores and a net loss of ₹5.09 crores, highlighting operational challenges and seasonal demand fluctuations in the agricultural sector. Despite a year-over-year profit increase, the current losses indicate difficulties in maintaining financial stability.

JK Agri Genetics reported a net profit of -2.51 crore for the fiscal year ending March 2025, with total operating income of 161.79 crore and significant liabilities of 268.56 crore. The company experienced negative operating profit and earnings per share, but had a positive cash flow from investing activities.

As of 20-Oct, JK Agri Genetics Ltd is seeing a price increase to 481.60, up 7.98%, with strong short-term performance but concerning long-term fundamentals, including negative growth in operating profits and low return on equity. Despite recent gains, the stock's outlook is complicated by declining investor participation and high volatility.

As of 17-Oct, JK Agri Genetics Ltd's stock price is 445.85, down 1.92%, with significant declines over the past week (5.44%) and month (13.33%). Despite a year-to-date increase of 2.90%, the stock has underperformed its sector and shows concerning long-term declines.

JK Agri Genetics reported a net loss of 2.51 crore for the year ending March 2025, with total operating income of 161.79 crore and an operating loss of 5.02 crore, reflecting a challenging financial position. The company had total assets and liabilities of 268.56 crore, with cash and cash equivalents at 5.00 crore.